Lung ultrasound comparison of two surfactant delivery methods in preterm babies
Part of Genetic & congenital, Lungs & breathing clinical trials.
This study compares two ways of giving surfactant (a lung-coating medicine) to newborns with breathing trouble: LISA (a gentler, less invasive method) versus traditional breathing tube delivery. Researchers will use ultrasound to see how the medicine spreads in each baby's lungs to find the best approach.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Baby is born between 24 and 42 weeks of pregnancy
- Baby has been diagnosed with Respiratory Distress Syndrome (RDS)—a breathing problem common in preterm babies
- Baby needs surfactant treatment within the first 3 days of life
- Baby was not intubated (put on a breathing tube) right at birth
- Baby did not receive surfactant as a preventive measure in the delivery room
- Baby does not have major birth defects affecting the lungs, heart, or chest wall
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a lung ultrasound score, a type of ultrasound, to decide when to give surfactant (a medicine that helps lungs work) to premature babies born between 27 and 35 weeks of pregnancy. It aims to reduce the need for more breathing support and avoid side effects.
This trial uses bedside ultrasound to see how well the lungs and blood flow are working in premature babies who receive surfactant, a medicine that helps their lungs open up.
This study uses lung ultrasound to see how different ways of giving surfactant (a medicine for breathing problems) affect preterm babies born before 32 weeks. It may help doctors choose the best method for your baby.
This study tests whether giving surfactant medication guided by a lung ultrasound, instead of by X-ray, helps preterm babies with breathing problems get better without needing a breathing tube. Babies in the study receive surfactant through a thin tube while still on non-invasive breathing support.
This trial compares two types of surfactant (Calfactant and Poractant Alfa) given through a less invasive method to very premature babies with breathing problems. It aims to see if one works better at helping them breathe without needing a breathing tube.
This trial tests two ways of giving surfactant (a lung medicine) to very premature babies with respiratory distress syndrome. It may help show which method works better and is safer for helping newborn lungs breathe.
Hear when a new Respiratory Distress Syndrome, Newborn trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.